BlossomHill Therapeutics, a clinical-stage biopharmaceutical company focused on cancer treatments, announced it will present at Guggenheim’s 3rd Annual Healthcare Innovations Conference on November 10, 2026. The company’s management will participate in a fireside chat and investor meetings, discussing their innovative small molecule medicines, including their lead drug candidate BH-30643 for EGFR-mutant non-small cell lung cancer. This event highlights BlossomHill’s ongoing efforts to develop targeted cancer therapies and engage with investors. An audio webcast of the presentation will be available on their website for 90 days.
BlossomHill Therapeutics' upcoming presentation at Guggenheim’s Healthcare Innovations Conference is contextually framed by Pluang's health sector market data as of Nov 03, 2026 19:02 WIB. Among 150 health-sector US stocks priced on Pluang, 74 advanced while 69 declined. BioNTech SE (BNTX) led with a 2.94% gain at USD 90.10 and a full buy order activity, contrasting with Travere Therapeutics Inc. (TVTX) which fell 3.98% to USD 47.30, and Cogent Biosciences Inc. (COGT) which rose 2.86% to USD 30.58.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
